In the UK, a range of treatments are available to help manage the symptoms and day-to-day challenges of inflammatory bowel diseases such as Crohn’s, including medication and lifestyle changes. However, for many people these approaches do not always provide sufficient relief.

As a result, an increasing number of individuals living with Crohn’s are exploring alternative options. Since medical cannabis was legalised in 2018, cannabis-based treatments, including cannabis oils, have become a popular and promising option for supporting symptom management alongside existing care.

Ulcerative colitis (UC) is a long-term inflammatory bowel disease that can be difficult and distressing to live with. It causes inflammation and ulceration in the lining of the colon and rectum, often leading to abdominal pain, cramping, and, in some cases, painful or swollen joints. These symptoms can significantly affect quality of life, and for many people, standard treatments may be ineffective or cause unwanted side effects.

As a result, some individuals choose to explore alternative approaches. Cannabis-based treatments for ulcerative colitis are available to eligible patients at Releaf and may be considered as part of a wider symptom management plan.